Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Expands clinical services' presence with acquisition of California-based Sherpa
September 10, 2018
By: Tim Wright
Editor-in-Chief, Contract Pharma
PCI Pharma Services (PCI) has acquired San Diego-based Sherpa Clinical Packaging, which ex-pands PCI’s U.S. operations to the West Coast. The acquisition strengthens PCI’s position in outsourced clinical trial support services. The addition of Sherpa’s capabilities also enables PCI to better support customers from early phases of clinical development through to commercial launch. Sherpa was founded in 2010 by Mark Paiz who identified the need for a clinical packaging ser-vices provider for the biopharmaceutical hubs on the West Coast. Sherpa’s core services include primary and secondary packaging and labeling for Phase I-IV studies, distribution, storage and returns. Sherpa’s state-of-the art facilities employ the latest cold chain technologies that in-clude handling products requiring labeling and kitting at frozen and refrigerated conditions. Sherpa is recognized for offering reliable, high quality, fast, and flexible clinical supply services for West Coast-based and global customers. Bill Mitchell, executive vice chairman, PCI said, “Mark and the team at Sherpa have done an excellent job of building a customer-centric organ-ization with a strong service reputation. Their dedication parallels our own commitment to provide the industry-leading customer experience, which makes them a natural fit for PCI.” Salim Haffar, PCI’s newly appointed chief executive officer, said, “I am delighted to join PCI during this period of rapid expansion and strategic investment which will allow PCI to better partner with our biopharma customers. The acquisition of Sherpa is the next logical step in our Clinical Services expansion strategy, further enhancing our development-stage capabilities and geographic presence.” Mark Paiz, founder and chief executive officer, Sherpa, said, “Sherpa’s success is due in large part to our commitment to deliver customers the highest levels of service, quality and reliabil-ity. I strongly believe PCI will continue to build on our success as well as enhance Sherpa with its global network and market-leading reputation.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !